These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6768573)

  • 1. Pharmacokinetics of sodium valproate in epileptic patients: prediction of maintenance dosage by single-dose study.
    Schapel GJ; Beran RG; Doecke CJ; O'Reilly WJ; Reece PA; Rischbieth RH; Sansom LN; Stanley PE
    Eur J Clin Pharmacol; 1980 Jan; 17(1):71-7. PubMed ID: 6768573
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of enteric-coated valproic acid.
    Albright PS; Bruni J; Suria D
    Ther Drug Monit; 1984; 6(1):21-3. PubMed ID: 6424275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state valproate pharmacokinetics during long term therapy.
    Eadie MJ; Heazlewood V; McKauge L; Tyrer JH
    Clin Exp Neurol; 1983; 19():183-91. PubMed ID: 6439443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-dose variation in plasma protein binding of sodium valproate in epileptic patients.
    Marty JJ; Kilpatrick CJ; Moulds RF
    Br J Clin Pharmacol; 1982 Sep; 14(3):399-404. PubMed ID: 6812608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose and steady state pharmacokinetics of valproic acid in adult epileptic patients.
    Miljković B; Pokrajac M; Varagić V; Lević Z
    Int J Clin Pharmacol Res; 1991; 11(3):137-41. PubMed ID: 1809700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients.
    Mihaly GW; Vajda FJ; Miles JL; Louis WJ
    Eur J Clin Pharmacol; 1979 Aug; 16(1):23-9. PubMed ID: 387418
    [No Abstract]   [Full Text] [Related]  

  • 7. [Correlation among sodium valproate concentrations in the total blood, plasma ultrafiltrate, and cerebrospinal fluid].
    Murata Y; Irimichi H; Okamoto M; Hirose K; Hayashi R; Miyamaru N
    No To Hattatsu; 1983 Sep; 15(5):390-5. PubMed ID: 6419752
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy.
    Shakir RA; Johnson RH; Lambie DG; Melville ID; Nanda RN
    Epilepsia; 1981 Feb; 22(1):27-33. PubMed ID: 6781888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of steady-state pharmacokinetics of valproic acid in children between monotherapy and multiple antiepileptic drug treatment.
    Chiba K; Suganuma T; Ishizaki T; Iriki T; Shirai Y; Naitoh H; Hori M
    J Pediatr; 1985 Apr; 106(4):653-8. PubMed ID: 3920375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on cerebrospinal fluid and saliva to serum concentration ratios of anticonvulsants--Phenytoin, Phenobarbital, Valproic Acid and Primidone in epileptic patients].
    Kido H
    Seishin Shinkeigaku Zasshi; 1982; 84(9):661-79. PubMed ID: 6820506
    [No Abstract]   [Full Text] [Related]  

  • 11. Absorption rate and bioavailability of valproic acid and its sodium from rectal dosage forms.
    Moolenaar F; Greving WJ; Huizinga T
    Eur J Clin Pharmacol; 1980 Apr; 17(4):309-15. PubMed ID: 6772450
    [No Abstract]   [Full Text] [Related]  

  • 12. Saliva and serum valproic acid levels in epileptic children.
    Fung K; Ueda K
    J Pediatr; 1982 Mar; 100(3):512. PubMed ID: 6801248
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability of valproate after gastric and direct intestinal administration in rats.
    Yeomans ND; Vajda FJ; Baldas J
    Clin Exp Pharmacol Physiol; 1982; 9(2):173-7. PubMed ID: 6813007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose kinetics and bioavailability of sodium-hydrogen divalproate.
    Anderson P; Elwin CE
    Clin Neuropharmacol; 1985; 8(2):156-64. PubMed ID: 3924399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of epilepsy. Superiority of a single daily dose of sodium valproate over fractionated doses].
    Giroud M; Dumas M; Escousse A; Dumas R
    Presse Med; 1988 Sep; 17(30):1544. PubMed ID: 2971952
    [No Abstract]   [Full Text] [Related]  

  • 16. Disposition of sodium valproate in epileptic patients.
    Perucca E; Gatti G; Frigo GM; Crema A; Calzetti S; Visintini D
    Br J Clin Pharmacol; 1978 Jun; 5(6):495-9. PubMed ID: 350251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions.
    Levy RH; Moreland TA
    Schweiz Rundsch Med Prax; 1984 Feb; 73(6):159-63. PubMed ID: 6424205
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of sodium valproate.
    Klotz U; Antonin KH
    Clin Pharmacol Ther; 1977 Jun; 21(6):736-43. PubMed ID: 324695
    [No Abstract]   [Full Text] [Related]  

  • 19. Sodium valproate: dose-plasma level relationships and interdose fluctuations.
    Vajda FJ; Mihaly GW; Miles JL; Morris PM; Bladin PF
    Clin Exp Neurol; 1978; 15():145-53. PubMed ID: 386306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of peritoneal dialysis on the single dose and steady state pharmacokinetics of valproic acid in a uremic epileptic child.
    Orr JM; Farrell K; Abbott FS; Ferguson S; Godolphin WJ
    Eur J Clin Pharmacol; 1983; 24(3):387-90. PubMed ID: 6407847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.